Data from a phase Ia clinical trial of an oral, long-acting integrase inhibitor (GS-1720) in development for HIV demonstrated ...

Revolutionary new HIV drugs are being made available in 120 low-income countries, but many important populations are being left out. Sophie Cousins reports.

ViiV Healthcare chief medical officer Harmony Garges said: “We know taking fewer medicines is an important consideration for ...

Gilead Sciences ( GILD) increased its growth forecast for the year on strong third quarter results, marking a shift away from ...

Gammora was shown to be safe and effective in eliminating HIV-infected cells without harming surrounding uninfected cells, ...

The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.

New Drug Shows Promise in Clearing HIV from Brain July 25, 2024 — An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a ...

Data from the Centers for Disease Control and Prevention released Tuesday shows meaningful declines in STI rates between 2022 ...

Negotiators at a U.N. conference in Colombia agreed to launch a fund for companies that make money from nature to give a ...

Specific subtypes and transmission clusters for HIV could require targeted interventions to control spread of HIV that is ...

“We are talking about sex and drugs—two topics that people call taboo,” said Brigitte Quenum, UNAIDS Regional Team Lead for ...

In recent years, HIV has spread rapidly among people who inject drugs, because users sometimes share needles when they don’t ...